Where Can I Get Microdose GLP-1: Compounding Rules Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Searching for where to get a microdose GLP-1 formulation is usually a compounding question in disguise. Microdosed and combination versions of these molecules do not come from the original manufacturer — they are prepared by licensed pharmacies, and the rules that govern them are specific. This guide from the PlexusDx Education Hub walks through what a compounder may legally make, how the 2024–2025 shortage timeline changed the landscape, and how to tell a legitimate source from a risky one.

Why a microdose is a compounding question

“Compounded” GLP-1 means a formulation of the active ingredient prepared by a licensed 503A compounding pharmacy under an individual prescriber order, rather than an FDA-approved brand product supplied by the drug maker. A microdose — a strength below the standard titration schedule — is one such patient-specific variation. So the honest answer to “where can I get it” starts with understanding who is allowed to make it and under what conditions.

The legal boundaries of a 503A pharmacy

503A pharmacies are state-licensed compounders that fill patient-specific prescriptions written by a valid prescriber. Federal law lets them compound in three broad situations: when a product is not commercially available, when a product sits on the FDA drug shortage list, and when an individual patient medically needs a formulation that differs in strength, combination, or vehicle from the commercial version. Both state pharmacy boards and the FDA keep oversight of that activity.

How the shortage timeline reshaped access

The FDA placed both semaglutide and tirzepatide on its shortage list in 2022. While those declarations stood, 503A pharmacies could compound the molecules under the shortage pathway. The agency then resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025. That narrowed the legitimate compounding window without closing it: compounded semaglutide and tirzepatide can still be prepared under the other two pathways — genuine patient-specific variations and combinations that are not commercially available — when there is a clinical justification.

Compounded and brand are not the same thing

A compounded product is legally and factually distinct from an FDA-approved brand. It does not pass through the same FDA manufacturing review, it relies on the individual pharmacy’s own quality processes, and it may carry a different vehicle, strength, or combination. Quality therefore varies from one pharmacy to the next, which is why verifying state licensure and, where available, third-party testing matters. Importantly, a compounded GLP-1 is not a “generic” in any regulatory sense of the word.

Where B12 and lower-dose formulations fit

Two variations show up often. Semaglutide combined with cyanocobalamin (vitamin B12) is common; the B12 can ease injection-site irritation for some people and may help those who are B12-deficient with energy and neurological health. Microdose formulations deliver less than a standard titration schedule and are sometimes chosen for patients who struggle with significant GI effects at label-directed strengths. The exact combination is patient-specific and set by the prescriber. PlexusDx lists a Microdose GLP-1 Protocol among its Weight Management Protocols.

Vetting a source before you commit

Confirm the pharmacy holds a license in your state and that a prescriber performs a real clinical evaluation, including a contraindication review. Treat any seller that ships without a prescription, takes only cryptocurrency, or markets a “research chemical” as a warning sign. A legitimate compounded product should arrive with patient-specific labeling, a lot number, a beyond-use date, and storage instructions consistent with USP <797> standards for nonsterile or, for injectables, USP <797>/<800> sterile standards.

The genetic layer beneath every GLP-1 choice

Whichever formulation you and your provider consider, the underlying biology is set upstream. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape baseline appetite regulation and energy balance. This is trait-level education, not a prediction of how you will respond to any drug — the test never forecasts medication response. Seeing that profile first is the test before you invest approach, turning guesswork into a grounded conversation with your healthcare provider.

Frequently Asked Questions

What does “compounded microdose GLP-1” actually mean?

It refers to a lower-strength formulation of the active ingredient prepared by a licensed 503A pharmacy under a prescriber order, rather than a brand product from the manufacturer. Strengths, vehicles, and combinations are patient-specific, so licensure and a genuine clinical evaluation should be confirmed before use.

Is a compounded version interchangeable with the brand?

No. Compounded products skip the FDA manufacturing review that brand products undergo and may differ in strength, vehicle, and combination. They are not generics, and quality depends on the individual pharmacy. Verify state licensure and, when possible, independent testing before deciding with your provider.

Why is B12 sometimes added to these formulations?

Cyanocobalamin is included in some compounded GLP-1 preparations because it may reduce injection-site discomfort for certain patients and can support those who are B12-deficient. It is a patient-specific choice made by the prescribing provider, not a standard ingredient that belongs in every formulation.

Does the Precision Peptide Genetic Test tell me which formulation to use?

No. It does not predict your response to compounded semaglutide, tirzepatide, or any specific formulation. It reviews pathway-level variants such as FTO and MC4R, and TCF7L2 that shape baseline energy-balance biology — upstream context for a conversation with your provider, not a treatment recommendation.

Start with the biology. Take the Precision Peptide Genetic Test, or browse the Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.